| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Calabrese Salvatore is a Chief Financial Officer at Gain Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2022 | GANX Gain Therapeutics, Inc. | Chief Financial Officer | Buy | 3,000 | $8,100.00 | $24,300,000.00 | -100% | +46.3% | +84.1% |